Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

ITALFARMACO SPA

Home Clinical Trial Sponsors and OrganizationsITALFARMACO SPA

ITALFARMACO SPA

ACTIVE

VIA DEI LAVORATORI 54, Cinisello Balsamo, Milano, Italywww.italfarmaco.comSubsidiary5,001–10,000 employeesEstablished: 1938-01-01

Part of ITALFARMACO HOLDING SPA

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Clinical Trials

8

8 active

Approvals

6

Total approvals

Agencies

1

Regulatory bodies

Founded

1938

Overview

Trial Phase Distribution

Phase

Trials

Share

Phase 1

8

100.0%

Trial Status Distribution

Active, not recruiting

8

100.0%

Clinical Trials

Trials sponsored by this organization (8)

A two-part study to assess the safety and preliminary efficacy of Givinostat in patients with JAK2V617F positive Polycythemia Vera

Active, not recruiting

Dec 201648 participants

ong-term Study Evaluating the Effect of Givinostat in Patients With Chronic Myeloproliferative Neoplasms

Active, not recruiting

Oct 201690 participants

ong-term Study Evaluating the Effect of givinostat in Patients With Chronic Myeloproliferative Neoplasms

Active, not recruiting

Dec 201490 participants

A two-part study to investigate the safety and preliminary efficacy of Givinostat in patients with Polycythemia Vera

Active, not recruiting

Feb 201452 participants

A two-part study to investigate the safety and preliminary efficacy of Givinostat in patients with Polycythemia Vera

Active, not recruiting

Jul 201348 participants

A two-part study to investigate the safety and preliminary efficacy of Givinostat in patients with Polycythemia Vera

Active, not recruiting

Jul 201348 participants

A two-part study to investigate the safety and preliminary efficacy of Givinostat in patients with Polycythemia Vera

Active, not recruiting

Apr 201348 participants

A two-part study to investigate the safety and preliminary efficacy of Givinostat in patients with Polycythemia Vera

Active, not recruiting

Apr 201352 participants

Approvals

Approvals by Agency

FDA

Food and Drug Administration

6

Approvals

Recent Approvals

Enoxaparin Sodium

Enoxaparin Sodium

fondaparinux sodium

fondaparinux sodium

News

No news articles found

On this page

Overview
Clinical Trials8
Approvals6
News

Back to Organizations